Loading…
Effect of Novel Amino Acids and Dipeptides Substituted 3-Morpholino Arecoline Derivatives as Muscarinic Receptor 1 Agonists in Alzheimer’s Dementia Models
A series of novel, potent and selective muscarinic receptor 1 agonists (M1 receptor agonists) that employ a key N -substituted morpholine arecoline moiety has been synthesized as part of research effort for the therapy of Alzheimer’s diseases. The ester group of arecoline (which is reported as mucar...
Saved in:
Published in: | International journal of peptide research and therapeutics 2009-12, Vol.15 (4), p.323-337 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of novel, potent and selective muscarinic receptor 1 agonists (M1 receptor agonists) that employ a key
N
-substituted morpholine arecoline moiety has been synthesized as part of research effort for the therapy of Alzheimer’s diseases. The ester group of arecoline (which is reported as mucarinic agonist) has been replaced by
N-
substituted morpholine ring. The structure activity relationship reveals that the increase in lipophilic carbon chain on the nitrogen atom of the morpholine ring increases the affinity of M1 receptor. In the present study, we are reporting
N
-amino acid substituted
9
(
a
–
k
) and dipeptides substituted
10
(
a
–
j
) and
11
(
a
–
j
) morpholino arecoline derivatives, along with their in vitro muscarinic binding studies by using [
3
H]QNB and also in vivo evaluation of memory and learning in male Wistar rats (passive avoidance test plus maze studies) as M1 receptor agonist. Some molecules from the dipeptide series (
10b
,
10c
and
10j
) showed potent M1 receptor agonist activity. Other derivatives also showed considerable M1 receptor binding affinity. |
---|---|
ISSN: | 1573-3149 1573-3904 |
DOI: | 10.1007/s10989-009-9194-z |